透過您的圖書館登入
IP:3.145.85.3
  • 期刊

The Impact of COVID-19 on Head and Neck Cancer Outpatient Care: Our Experience at a Tertiary Care Center in Southern Taiwan

摘要


Objective: During the COVID-19 pandemic, outpatient visits have decreased due to the risk of exposure to aerosolized respiratory secretions, especially in the otorhinolaryngologic clinic. Delay in diagnosis and treatment for head and neck cancer was a major concern. We tried to assess the impact of COVID-19 on outpatient care for patients with head and neck cancers at E-Da Hospital. Methods: We reviewed the medical records of all outpatients with newly diagnosed head and neck cancers and those diagnosed with head and neck cancers at the Department of Otorhinolaryngology of E-Da Hospital between January and June, 2020. The medical records of patients with their head and neck cancers diagnosed between January and June, 2019 were scrutinized for comparison. We utilized SigmaPlot 13 (Systat Software, San Jose, CA) with Chi-squared test for statistical analysis with significance set at p <0.05. Results: There were a total of 24,346 outpatient visits at our otorhinolaryngologic department between January and June, 2019 in comparison with 18,983 visits (22% reduction) during the COVID-19 pandemic in 2020. The total numbers of head and neck cancer outpatients were 6,386 in 2019 and 5,915 in 2020, and the proportion of head and neck cancer outpatients to total outpatients showed significant increase during the COVID-19 pandemic (31.2% in 2020 vs. 26.2% in 2019, p <0.001). A significant increase in the proportion of patients with newly diagnosed head and neck cancers to the total number of outpatients was also noted in 2020 compared to that in 2019 (1.3% vs. 1.0% of total outpatient cases, p=0.007). The proportion of patients with newly diagnosed late-stage head and neck cancers to the total number of outpatients has slightly increased in 2020 compared to that in 2019 (0.64% vs. 0.62% of the total number of outpatient cases, p=0.864). Conclusions: The impact of COVID-19 on head and neck cancer care E-Da Hospital is negligible due to effective infection control policies, a trusting relationship between the patients and the medical professionals, adequate recognition of the need for timely treatment of head and neck cancers among the general public, as well as a strong sense of social responsibility among physicians. Nevertheless, a flexible ambulatory care program for patients with head and neck cancers according to the severity of the pandemic is still warranted for maintaining a delicate balance between the delivery of optimal care and the risk of nosocomial infection through the dissemination of respiratory secretions.

參考文獻


Shuman AG, Campbell BH, AHNS Ethics & Professionalism Service: Ethical framework for head and neck cancer care impacted by COVID-19. Head & Neck 2020; 42:1214–1217
Meng L, Hua F, Bian Z: Coronavirus disease 2019 (COVID‐19): emerging and future challenges for dental and oral medicine. J Dent Res 2020;99(5):481‐487
Zou L, Ruan F, Huang M, et al: SARS‐CoV‐2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382(12):1177‐1179
Liang W, Guan W, Chen R, et al: Cancer patients in SARS- CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21(3):335-337.
Kasle DA, Torabi SJ, Savoca EL, et al: Outpatient Otolaryngology in the Era of COVID-19: A Data-Driven Analysis of Practice Patterns. Otolaryngol Head Neck Surg 2020 ;163(1):138-144.

延伸閱讀